Gastrin and cholecystokinin peptide-based radiopharmaceuticals: An in vivo and in vitro comparison

Journal of Peptide Science

Volumn 17, Issue 5, 2011, Pages 405-412

  Tornesello, Anna Lucia ^c   Aurilio, Michela ^b   Accardo, Antonella ^a   Tarallo, Laura ^b   Barbieri, Antonio ^b   Arra, Claudio ^b   Tesauro, Diego ^a   Morelli, Giancarlo ^a   Aloj, Luigi ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c INBIOS srl   (Italy)

Author keywords

Ga and In complexes; Minigastrin and CCK8 peptide conjugates; Nuclear medicine

Indexed keywords

CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ OCTAPEPTIDE DERIVATIVE; GALLIUM 68; GASTRIN DERIVATIVE; INDIUM 111;

ANIMAL EXPERIMENT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG STRUCTURE; DRUG TRANSPORT; DRUG UPTAKE; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; ISOTOPE LABELING; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CELL LINE, TUMOR; CHOLECYSTOKININ; GALLIUM RADIOISOTOPES; GASTRINS; HUMANS; INDIUM RADIOISOTOPES; MICE; MICE, NUDE; NUCLEAR MEDICINE; PEPTIDES; RECEPTOR, CHOLECYSTOKININ B;

EID: 79953789669     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.1327     Document Type: Article

References (27)

1. Behr TM, Gotthardt M, Barth A, Behe M. Imaging tumors with peptide-based radioligands. Q. J. Nucl. Med. 2001; 45: 189-200.
2. Reubi JC. Peptide receptors as molecular targets for cancer diagnosis and therapy. Endocr. Rev. 2003; 24: 389-427.
3. Kwekkeboom D, Krenning EP, De Jong M. Peptide receptor imaging and therapy. J. Nucl. Med. 2000; 41: 1704-1713.
4. Kwekkeboom DJ, Mueller-Brand J, Paganelli G, Anthony LB, Pauwels S, Kvols LK, O'Dorisio TM, Valkema R, Bodei L, Chinol M, Maecke HR, Krenning EP. Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs. J. Nucl. Med. 2005; 46 (Suppl. 1)): 62S-66S.
5. Wank SA. G protein-coupled receptors in gastrointestinal physiology. I. CCK receptors: an exemplary family. Am. J. Physiol. 1998; 274: G607-613.
6. Reubi JC, Schaer JC, Waser B. Cholecystokinin CCK)-A and CCK-B/gastrin receptors in human tumors. Cancer Res. 1997; 57: 1377-1386.
7. Aloj L, Caraco C, Panico M, Zannetti A, Del Vecchio S, Tesauro D, De Luca S, Arra C, Pedone C, Morelli G, Salvatore M. In vitro and in vivo evaluation of 111In-DTPAGlu-G-CCK8 for cholecystokinin-B receptor imaging. J. Nucl. Med. 2004; 45: 485-494.
8. Behr TM, Behe MP. Cholecystokinin-B/Gastrin receptor-targeting peptides for staging and therapy of medullary thyroid cancer and other cholecystokinin-B receptor-expressing malignancies. Semin. Nucl. Med. 2002; 32: 97-109.
9. Behe M, Becker W, Gotthardt M, Angerstein C, Behr TM. Improved kinetic stability of DTPA- dGlu as compared with conventional monofunctional DTPA in chelating indium and yttrium: preclinical and initial clinical evaluation of radiometal labelled minigastrin derivatives. Eur. J. Nucl. Med. Mol. Imaging 2003; 30: 1140-1146.
10. Good S, Walter MA, Waser B, Wang X, Muller-Brand J, Behe MP, Reubi JC, Maecke HR. Macrocyclic chelator-coupled gastrin-based radiopharmaceuticals for targeting of gastrin receptor-expressing tumours. Eur. J. Nucl. Med. Mol. Imaging 2008; 35: 1868-1877.
11. Reubi JC, Waser B, Schaer JC, Laederach U, Erion J, Srinivasan A, Schmidt MA, Bugaj JE. Unsulfated DTPA- and DOTA-CCK analogs as specific high-affinity ligands for CCK-B receptor-expressing human and rat tissues in vitro and in vivo. Eur. J. Nucl. Med. 1998; 25: 481-490.
12. De Jong M, Bakker WH, Bernard BF, Valkema R, Kwekkeboom DJ, Reubi JC, Srinivasan A, Schmidt M, Krenning EP. Preclinical and initial clinical evaluation of 111In-labeled nonsulfated CCK8 analog: a peptide for CCK-B receptor-targeted scintigraphy and radionuclide therapy. J. Nucl. Med. 1999; 40: 2081-2087.
13. Kwekkeboom DJ, Bakker WH, Kooij PP, Erion J, Srinivasan A, De Jong M, Reubi JC, Krenning EP. Cholecystokinin receptor imaging using an octapeptide DTPA-CCK analogue in patients with medullary thyroid carcinoma. Eur. J. Nucl. Med. 2000; 27: 1312-1317.
14. Nock BA, Maina T, Behe M, Nikolopoulou A, Gotthardt M, Schmitt JS, Behr TM, Macke HR. CCK-2/gastrin receptor-targeted tumor imaging with 99m)Tc-labeled minigastrin analogs. J. Nucl. Med. 2005; 46: 1727-1736.
15. Froberg AC, de Jong M, Nock BA, Breeman WA, Erion JL, Maina T, Verdijsseldonck M, de Herder WW, van der Lugt A, Kooij PP, Krenning EP. Comparison of three radiolabelled peptide analogues for CCK-2 receptor scintigraphy in medullary thyroid carcinoma. Eur. J. Nucl. Med. Mol. Imaging 2009; 36: 1265-1272.
16. Gabriel M, Decristoforo C, Kendler D, Dobrozemsky G, Heute D, Uprimny C, Kovacs P, Von Guggenberg E, Bale R, Virgolini IJ. 68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT. J. Nucl. Med. 2007; 48: 508-518.
17. Hofmann M, Maecke H, Borner R, Weckesser E, Schoffski P, Oei L, Schumacher J, Henze M, Heppeler A, Meyer J, Knapp H. Biokinetics and imaging with the somatostatin receptor PET radioligand 68)Ga-DOTATOC: preliminary data. Eur. J. Nucl. Med. 2001; 28: 1751-1757.
18. Behr TM, Behe M, Angerstein C, Gratz S, Mach R, Hagemann L, Jenner N, Stiehler M, Frank-Raue K, Raue F, Becker W. Cholecystokinin-B/gastrin receptor binding peptides: preclinical development and evaluation of their diagnostic and therapeutic potential. Clin. Cancer Res. 1999; 5: 3124s-3138s.
19. Behr TM, Jenner N, Behe M, Angerstein C, Gratz S, Raue F, Becker W. Radiolabeled peptides for targeting cholecystokinin-B/gastrin receptor-expressing tumors. J. Nucl. Med. 1999; 40: 1029-1044.
20. Behe M, Kluge G, Becker W, Gotthardt M, Behr TM. Use of polyglutamic acids to reduce uptake of radiometal-labeled minigastrin in the kidneys. J. Nucl. Med. 2005; 46: 1012-1015.
21. Anelli PL, Fedeli F, Gazzotti O, Lattuada L, Lux G, Rebasti F. L-Glutamic acid and L-lysine as useful building blocks for the preparation of bifunctional DTPA-like ligands. Bioconjugate Chem. 1999; 10: 137-140.
22. Zhernosekov KP, Filosofov DV, Baum RP, Aschoff P, Bihl H, Razbash AA, Jahn M, Jennewein M, Rosch F. Processing of generator-produced 68Ga for medical application. J. Nucl. Med. 2007; 48: 1741-1748.
23. Pellegrini M, Mierke DF. Molecular complex of cholecystokinin-8 and N-terminus of the cholecystokinin A receptor by NMR spectroscopy. Biochemistry 1999; 38: 14775-14783.
24. Roosenburg S, Laverman P, van Delft FL, Boerman OC. Radiolabeled CCK/gastrin peptides for imaging and therapy of CCK2 receptor-expressing tumors. Amino Acids 2010; DOI: 10.1007/s00726-010-0501-y.
25. Gotthardt M, van Eerd-Vismale J, Oyen WJ, de Jong M, Zhang H, Rolleman E, Maecke HR, Behe M, Boerman O. Indication for different mechanisms of kidney uptake of radiolabeled peptides. J. Nucl. Med. 2007; 48: 596-601.
26. Otsuki H, Brunetti A, Owens ES, Finn RD, Blasberg RG. Comparison of Iron-59, Indium-111, and Gallium-68 transferrin as a macromolecular tracer of vascular permeability and the transferrin receptor. J. Nucl. Med. 1989; 30: 1676-1685.
27. Mather SJ, McKenzie AJ, Sosabowski JK, Morris TM, Ellison D, Watson SA. Selection of radiolabeled gastrin analogs for peptide receptor-targeted radionuclide therapy. J. Nucl. Med. 2007; 48: 615-622.